| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Chief Executive Officer
2 companies
Flesher Gregory J. serves as a Chief Executive Officer at ELDN and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 2 buys and 2 sells. Those positions are worth an estimated $300K at current prices.
The biggest single holding is ELDN (~$300K) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 44,321 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2021 | OKUR Onkure Therapeutics, Inc. | President And CEO | Buy | 8,000 | $8.00 | $64,000.00 | New | +13.2% | -52.4% | |
| May 21, 2019 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 14,638 | $1.95 | $28,566.46 | -8.5% | - | - | |
| May 10, 2017 | ELDN Eledon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 58,959 | $9.99 | $589,000.41 | +103.6% | - | - |